rewirebio.iobenchmarks
Protocol

Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)

Apply the OPA1-tuned thresholds unchanged to 76 spliceogenic and 107 benign substitutions in 65 genes; report accuracy, PPV, type I error, specificity, sensitivity and type II error.

12 evaluations · 72 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

12 recorded evaluations, 72 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

12 evaluations · 72 results. Different protocols are not a single leaderboard.

Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV) · Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

Sorted by Accuracy (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

All 72 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
71.6% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'Accuracy' (PDF page 9 of 11)
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
67.2% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'PPV' (PDF page 9 of 11)
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
43 (56.6%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'Sensitivity' (PDF page 9 of 11)
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
86 (80.4%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'Specificity' (PDF page 9 of 11)
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
21 (19.6%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'Type I error' (PDF page 9 of 11)
Configuration: AlphaGenome (Either Module) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
33 (43.4%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome (Either Module) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME (EITHER MODULE)', column 'Type II error' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
68.9% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'Accuracy' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
68.6% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'PPV' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
35 (46.1%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'Sensitivity' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
91 (85.0%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'Specificity' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
16 (15.0%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'Type I error' (PDF page 9 of 11)
Configuration: AlphaGenome Junction Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
41 (53.9%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Junction Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME JUNCTION SCORER', column 'Type II error' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
67.2% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'Accuracy' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
67.4% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'PPV' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
31 (40.8%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'Sensitivity' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
92 (86.0%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'Specificity' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
15 (13.9%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'Type I error' (PDF page 9 of 11)
Configuration: AlphaGenome Splice Scorer (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
45 (59.2%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice Scorer on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'ALPHAGENOME SPLICE SCORER', column 'Type II error' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
80.9% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'Accuracy' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
87.5% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'PPV' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
49 (64.5%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'Sensitivity' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
100 (93.5%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'Specificity' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
7 (6.5%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'Type I error' (PDF page 9 of 11)
Configuration: Borzoi (128-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
27 (35.5%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (128-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (128-BP)', column 'Type II error' (PDF page 9 of 11)
Configuration: Borzoi (32-bp) (Alavi 2026)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
86.9% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Borzoi (32-bp) on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026) · Table IV, row 'BORZOI (32-BP)', column 'Accuracy' (PDF page 9 of 11)

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

External evaluations
12

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Training-set class prior where supervised fitting is permitted

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Regularised classifier on simple permitted features, or protocol's conventional reference

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-10-22-1b7cf027e4f6. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: rna-splicing-20261011-alavi2026-protocol-multigene

areas
dna-genomes
contexts
clinical_research
protocol
Apply the OPA1-tuned thresholds unchanged to 76 spliceogenic and 107 benign substitutions in 65 genes; report accuracy, PPV, type I error, specificity, sensitivity and type II error.
version
Table IV
source locator
Table IV; Methods A; Results F 'Multi-gene benchmarking'
limitations
Spliceogenic positives are canonical splice-site substitutions only; benign controls are ClinVar intronic substitutions from 46 of the 65 genes.; Positives were confirmed by RNA studies in the cited sources (references 13 and 14); this preprint does not restate the assay per variant.; Thresholds were set by one-dimensional grid search on the OPA1 evaluation sets, optimising accuracy and specificity (Methods B).; Single-author preprint; no uncertainty intervals are printed for the tabulated metrics.; Foundation-model scores are zero-shot log-likelihood ratios with author-chosen context windows, aggregation and strand rules (Methods F to H).; Genos 10B ClinVar is fine-tuned on ClinVar labels and the benign controls are ClinVar variants; training overlap is not tested in the source.
Related records

Suggest a correction